X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
index medicus (24) 24
gastroenterology & hepatology (20) 20
gastroenterology and hepatology (17) 17
middle aged (17) 17
male (16) 16
oncology (15) 15
cancer (14) 14
aged (13) 13
female (13) 13
endoscopy (10) 10
squamous-cell carcinoma (9) 9
adult (8) 8
esophageal cancer (8) 8
surgery (8) 8
aged, 80 and over (7) 7
care and treatment (7) 7
chemotherapy (7) 7
medicine & public health (7) 7
gastroenterology (6) 6
hepatology (6) 6
medical colleges (6) 6
retrospective studies (6) 6
barretts-esophagus (5) 5
diagnosis (5) 5
endoscopic surgery (5) 5
prospective studies (5) 5
stomach neoplasms - diagnosis (5) 5
analysis (4) 4
early detection (4) 4
endoscopy, gastrointestinal - methods (4) 4
head (4) 4
magnifying endoscopy (4) 4
oncology, experimental (4) 4
research (4) 4
squamous cell carcinoma (4) 4
surgical oncology (4) 4
treatment outcome (4) 4
adenomatous polyposis coli - surgery (3) 3
chemoradiotherapy (3) 3
cisplatin (3) 3
diagnosis, differential (3) 3
differential-diagnosis (3) 3
duodenal neoplasms - diagnosis (3) 3
duodenal neoplasms - surgery (3) 3
early detection of cancer (3) 3
endoscopic mucosal resection (3) 3
endoscopic resection (3) 3
endoscopy, gastrointestinal (3) 3
esophageal neoplasms - drug therapy (3) 3
esophageal stenosis - therapy (3) 3
follow-up studies (3) 3
gastric-cancer (3) 3
gastrointestinal neoplasms - diagnosis (3) 3
gastrointestinal neoplasms - pathology (3) 3
identification (3) 3
metastasis (3) 3
narrow band imaging (3) 3
neoplasm staging (3) 3
original article (3) 3
phase-ii (3) 3
radiation therapy (3) 3
research article (3) 3
risk factors (3) 3
submucosal dissection (3) 3
tissue (3) 3
trial (3) 3
universities and colleges (3) 3
young adult (3) 3
5-fluorouracil (2) 2
abridged index medicus (2) 2
adenocarcinoma - diagnosis (2) 2
adenoma (2) 2
adolescent (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
autopsy (2) 2
benign (2) 2
cancer research (2) 2
cancer therapies (2) 2
carcinoma (2) 2
carcinoma, squamous cell - secondary (2) 2
carcinoma, squamous cell - surgery (2) 2
carcinoma, squamous cell - therapy (2) 2
chemoprevention (2) 2
colonic polyps (2) 2
colorectal surgery (2) 2
conventional colonoscopy (2) 2
diagnostic imaging - methods (2) 2
differential diagnosis (2) 2
diffusion magnetic resonance imaging (2) 2
drug dosages (2) 2
duodenal neoplasms - pathology (2) 2
early diagnosis (2) 2
endoscopic balloon dilation (2) 2
endoscopic submucosal dissection (2) 2
epidemiology (2) 2
equipment design (2) 2
esophageal neoplasms - pathology (2) 2
esophageal neoplasms - surgery (2) 2
esophageal neoplasms - therapy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 5, pp. 6595 - 6606
Hyponatremia is a common electrolyte abnormality in cancer patients who receive chemotherapy. Among anticancer agents, platinum-based agents are reported to... 
Carboplatin | Platinum agent | Hyponatremia | Cisplatin | Risk factors
Journal Article
Journal Article
Journal Article
Pharmacology, ISSN 0031-7012, 06/2019, Volume 104, Issue 1-2, pp. 51 - 56
Mesalazine is the gold standard drug for treatment of ulcerative colitis (UC). Here, we describe 4 cases of familial adenomatous polyposis (FAP) patients with... 
Research Article | Mesalazine | Chemoprevention | Familial adenomatous polyposis | 5-aminosalicylic acid | PHARMACOLOGY & PHARMACY | RELEASE MESALAZINE
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 7/2011, Volume 68, Issue 1, pp. 263 - 266
To establish an appropriate administration schedule for oxaliplatin in FOLFOX plus bevacizumab therapy for a hemodialytic patient.A 50-year-old man on chronic... 
Oxaliplatin | Medicine & Public Health | Hemodialysis | Colorectal cancer | Renal failure | FOLFOX plus bevacizumab | Oncology | Cancer Research | Pharmacology/Toxicology | DYSFUNCTION-WORKING-GROUP | TUMOR RESPONSE | PHARMACODYNAMICS | TOXICITY | CLINICAL PHARMACOKINETICS | METASTATIC COLORECTAL-CANCER | CHEMOTHERAPY | CISPLATIN | ONCOLOGY | PHARMACOLOGY & PHARMACY | IMPAIRED RENAL-FUNCTION | EXPOSURE | Antineoplastic Combined Chemotherapy Protocols - blood | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Male | Antineoplastic Agents - administration & dosage | Bevacizumab | Antibodies, Monoclonal, Humanized | Fluorouracil - therapeutic use | Organoplatinum Compounds - administration & dosage | Fluorouracil - blood | Organoplatinum Compounds - pharmacokinetics | Colorectal Neoplasms - drug therapy | Leucovorin - therapeutic use | Antineoplastic Agents - pharmacokinetics | Liver Neoplasms - secondary | Organoplatinum Compounds - blood | Leucovorin - blood | Liver Neoplasms - drug therapy | Leucovorin - pharmacokinetics | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antineoplastic Agents - blood | Fluorouracil - pharmacokinetics | Organoplatinum Compounds - therapeutic use | Renal Dialysis | Antimitotic agents | Care and treatment | Colon cancer | Metastasis | Universities and colleges | Antineoplastic agents | Cancer | Index Medicus
Journal Article